Detalhe da pesquisa
1.
Validation of a blood protein signature for non-small cell lung cancer.
Clin Proteomics
; 11(1): 32, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25114662
2.
HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms.
EBioMedicine
; 93: 104655, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327673
3.
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics.
Diabetes Care
; 43(9): 2183-2189, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527800
4.
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study.
Diabetes Care
; 43(4): 843-851, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988066
5.
Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Clin Lung Cancer
; 18(2): e99-e107, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836219
6.
Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851.
Diabetes Care
; 44(4): 1071, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483359
7.
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.
PLoS One
; 7(10): e46091, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23056237
8.
Protein signature of lung cancer tissues.
PLoS One
; 7(4): e35157, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22509397
9.
Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
PLoS One
; 5(12): e15003, 2010 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21170350
10.
Aptamer-based multiplexed proteomic technology for biomarker discovery.
PLoS One
; 5(12): e15004, 2010 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21165148